What is a typical first-line acute treatment for a healthy adult with moderate migraine without cardiovascular risk?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

What is a typical first-line acute treatment for a healthy adult with moderate migraine without cardiovascular risk?

The main idea is to use a fast-acting, migraine-specific therapy as the first choice to abort a moderate acute attack in someone without cardiovascular risk. A triptan taken at onset is best because it directly targets the vascular and neural drivers of migraine by activating 5-HT1B/1D receptors, which helps constrict dilated cranial vessels and reduce the release of inflammatory neuropeptides, leading to swift relief. For a moderate attack, combining the triptan with an NSAID or acetaminophen often provides greater and more durable relief than a triptan alone, since NSAIDs address inflammatory mediators and add analgesia, lowering the chance of relapse. Opioid analgesics are avoided as first-line due to risks of dependency and medication-overuse headache, and ergot derivatives carry more safety concerns and are generally not preferred when a safe, effective triptan option exists. Preventive mood stabilizers aren’t used for acute treatment; they’re intended to reduce attack frequency over time. In someone healthy with no cardiovascular risk, this combination approach offers rapid, reliable relief with a favorable safety profile.

The main idea is to use a fast-acting, migraine-specific therapy as the first choice to abort a moderate acute attack in someone without cardiovascular risk. A triptan taken at onset is best because it directly targets the vascular and neural drivers of migraine by activating 5-HT1B/1D receptors, which helps constrict dilated cranial vessels and reduce the release of inflammatory neuropeptides, leading to swift relief. For a moderate attack, combining the triptan with an NSAID or acetaminophen often provides greater and more durable relief than a triptan alone, since NSAIDs address inflammatory mediators and add analgesia, lowering the chance of relapse. Opioid analgesics are avoided as first-line due to risks of dependency and medication-overuse headache, and ergot derivatives carry more safety concerns and are generally not preferred when a safe, effective triptan option exists. Preventive mood stabilizers aren’t used for acute treatment; they’re intended to reduce attack frequency over time. In someone healthy with no cardiovascular risk, this combination approach offers rapid, reliable relief with a favorable safety profile.

More practice questions